Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lin

Showing results (751-760 of 792) with videos related to

Pageof 80
Sort By:
The New England Journal of Medicine|December 19, 2008
Dicer, Drosha, and outcomes in patients with ovarian cancerWilliam M Merritt, Yvonne G Lin, Liz Y Han, et al.
Cell Reports|December 12, 2019
A Study of High-Grade Serous Ovarian Cancer Origins Implicates the SOX18 Transcription Factor in Tumor DevelopmentKate Lawrenson, Marcos A S Fonseca, Annie Y Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Therapeutic Targeting of ATP7B in Ovarian CarcinomaLingegowda S Mangala, Vesna Zuzel, Rosemarie Schmandt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2021
Editor's Note: Therapeutic Targeting of ATP7B in Ovarian CarcinomaLingegowda S Mangala, Vesna Zuzel, Rosemarie Schmandt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Targeting aurora kinase with MK-0457 inhibits ovarian cancer growthYvonne G Lin, Anand Immaneni, William M Merritt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2021
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)Kathleen N Moore, Michael Bookman, Jalid Sehouli, et al.
Zhonghua Fang She Xue Za Zhi Chinese Journal of Radiology|February 1, 1983
[Percutaneous transhepatic cholangiography and drainage]X R Chen, X Y Ni, R X Huang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2024
ENGOT-en11/GOG-3053/KEYNOTE-B21: a randomised, double-blind, phase III study of pembrolizumab or placebo plus adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed, high-risk endometrial cancerT Van Gorp, D Cibula, W Lv, et al.
Nature Medicine|July 25, 2006
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinomaPremal H Thaker, Liz Y Han, Aparna A Kamat, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2026
Cerebrovascular Single-Nucleus RNA-Seq Reveals Heat Shock Activation and Vascular Remodeling in Alzheimer's Disease and Primary TauopathiesL D Estrella, S Dasgupta, A Gundavelli, et al.
Pageof 80

Showing results (751-760 of 792) with videos related to

Sort By:
Pageof 80
The New England Journal of Medicine|December 19, 2008
Dicer, Drosha, and outcomes in patients with ovarian cancerWilliam M Merritt, Yvonne G Lin, Liz Y Han, et al.
Cell Reports|December 12, 2019
A Study of High-Grade Serous Ovarian Cancer Origins Implicates the SOX18 Transcription Factor in Tumor DevelopmentKate Lawrenson, Marcos A S Fonseca, Annie Y Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Therapeutic Targeting of ATP7B in Ovarian CarcinomaLingegowda S Mangala, Vesna Zuzel, Rosemarie Schmandt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2021
Editor's Note: Therapeutic Targeting of ATP7B in Ovarian CarcinomaLingegowda S Mangala, Vesna Zuzel, Rosemarie Schmandt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Targeting aurora kinase with MK-0457 inhibits ovarian cancer growthYvonne G Lin, Anand Immaneni, William M Merritt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2021
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)Kathleen N Moore, Michael Bookman, Jalid Sehouli, et al.
Zhonghua Fang She Xue Za Zhi Chinese Journal of Radiology|February 1, 1983
[Percutaneous transhepatic cholangiography and drainage]X R Chen, X Y Ni, R X Huang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2024
ENGOT-en11/GOG-3053/KEYNOTE-B21: a randomised, double-blind, phase III study of pembrolizumab or placebo plus adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed, high-risk endometrial cancerT Van Gorp, D Cibula, W Lv, et al.
Nature Medicine|July 25, 2006
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinomaPremal H Thaker, Liz Y Han, Aparna A Kamat, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2026
Cerebrovascular Single-Nucleus RNA-Seq Reveals Heat Shock Activation and Vascular Remodeling in Alzheimer's Disease and Primary TauopathiesL D Estrella, S Dasgupta, A Gundavelli, et al.
Pageof 80